Author

JOSE MANUEL BENITEZ CANTERO 1

1 Hospital Universitario Reina Sofía and IMIBIC,Córdoba,Spain

Epidemiology, clinical characteristics, evolution and treatments in newly diagnosed inflammatory bowel disease (IBD): results from the nationwide EpidemIBD study of GETECCU

Maria Chaparro Sanchez, Manuel Barreiro-de Acosta, JOSE MANUEL BENITEZ CANTERO, Jose Luis Cabriada, María José Casanova, Daniel Ceballos, María Esteve, Hipólito Fernández, Daniel Ginard, Fernando Gomollon, Rufo H. Lorente, Pilar Nos, Sabino Riestra, Montserrat Rivero, Pilar Robledo, Cristina Rodriguez, Beatriz Sicilia, Emi

METHOTREXATE AFTER ANTI-TNF-α FAILURE IN CROHN'S DISEASE: A RETROSPECTIVE SERIES FROM THE ENEIDA REGISTRY. TEACHING AN OLD DOG NEW TRICKS?

Francisco Mesonero, Jesus Castro Poceiro, Elena Ricart, JOSE MANUEL BENITEZ CANTERO, Blau Camps Aler, Jordi Guardiola, Marisa Iborra, Alicia López-García, Paola Francesca Torres Rodríguez, María Esteve, Joan Tosca, Federico Bertoletti, Pedro Almela, Xavier Calvet, Maria Isabel Vera, Luis Bujanda Fernández de Piérola, Fernan

Proteomic markers of response to anti-TNF drugs in Crohn´s disease

Rosario Medina Medina, Eva Iglesias Flores, JOSE MANUEL BENITEZ CANTERO, Sandra Marín Pedrosa, Isabel Salgueiro Rodriguez, Gustavo Ferrín Sánchez, Clara I. Linares Luna, Sandra González Rubio, Pilar Soto Escribano, Beatriz Gros Alcalde, Cristina Moral, Francisco Álvarez, Manuel Rodríguez Perálvarez, Eduardo Chicano Gálvez, Ig

TOLERANCE TO ADALIMUMAB CITRATE-FREE AND CITRATE FORMULATIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Beatriz Gros, Pablo Rodríguez Fernández, Sandra Marin, Pilar Soto, Rosario Medina Medina, JOSE MANUEL BENITEZ CANTERO, Eva Iglesias-Flores

Item 1 - 4 / 4
1